XRP Targets $2.40 Recovery as AlphaPepe Offers Early Entry Advantage

XRP is showing signs of recovery, with traders eyeing a return to the $2.40 level, a high reached earlier in 2026. The cryptocurrency has rebounded strongly in the third quarter, gaining approximately 48%, its best performance in four years. Currently trading around $1.50, XRP faces resistance near $1.70, which it must overcome to strengthen the bullish case for a return to $2.40.

Meanwhile, AlphaPepe is offering an alternative investment opportunity. The project is in Stage 21, with ALPE tokens available at $0.03237. Buyers are entering before ALPE's planned Q1 2027 DEX launch and before it hits public exchanges. This early entry is a key advantage, as XRP buyers are betting on a recovery to a previously seen high, while ALPE buyers are positioning themselves before any public-market trading begins.

AlphaPepe has already attracted over 12,300 holders, with more than 100 new holders joining daily. The project has also undergone security audits, receiving a 10/10 BlockSAFU audit rating and a Coinsult audit, which adds credibility to its offering. The growing community and early entry window make AlphaPepe an attractive option for those seeking asymmetric upside.

While XRP's recovery to $2.40 is still a possibility, the challenge lies in the substantial move required from its current price. AlphaPepe, on the other hand, offers the opportunity to enter before its first exchange run, providing a different kind of investment appeal. For traders deciding between a mature recovery and an earlier-stage opportunity, AlphaPepe presents a clearer high-upside choice.